Adocia
OTCMKTS:ADOCYAdocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as M1Pram, a metabolite of insulin glargine and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and BioChaperone GluExe, a combination of glucagon and exenatide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.
MDxHealth
OTCMKTS:MXDHFMDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
Thomas Cook Group
OTCMKTS:TCKGYThomas Cook Group Plc engages in the provision of travel services. The company was founded on February 8, 2007 and is headquartered in Manchester, the United Kingdom.
Wirecard
OTCMKTS:WCAGYWirecard AG engages in the provision of software and information technology for payment processing and issuing products in the field of outsourcing and white label industry. It operates through the following segments: Payment Processing and Risk Management (PP&RM); Acquiring and Issuing (A&I); and Call Center and Communication Services (CC&CS). The PP&RM segment refers to products and services related to electronic payment processing, risk management, and other value added services. The A&I segment offers settlement services for credit card sales for online and terminal payments. The CC&CS segment reports the complete value-added scope of its call center activities, with other products. The company was founded on May 6, 1999 and is headquartered in Munich, Germany.